+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

BioStem Technologies

BSEMOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$13.19

-0.36-2.66%

At close: -

$14.60

1.4110.69%

After Hours: Dec 23, 8:30 AM EDT

BioStem Technologies (BSEM) Forecast

News

Earnings BioStem Technologies (BSEM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for BioStem Technologies (OTC:BSEM) Stock

BioStem Technologies Stock (OTC: BSEM)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, September 11, 2023

NovaBay Pharmaceuticals Announces Agreement w...
Benzinga Newsdesk

Monday, January 30, 2023

How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond
Gita Karunakaran - Sponsored

Monday, January 23, 2023

BioStem Reveals Plans For New Products, Expanded Sales And Manufacturing Capabilities At Dawson James Small Cap Growth Conference
Rachael Green - Sponsored

Tuesday, January 17, 2023

Benzinga Speaks To BioStem Technologies About How Its Technology Is Changing The World Of Wound Care
Faith Ashmore - Sponsored

Friday, January 13, 2023

2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion
Gita Karunakaran - Sponsored

Monday, November 07, 2022

Zacks Investment Research Initiates Coverage ...
Benzinga Newsdesk

Thursday, September 22, 2022

BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Zacks Small Cap Research

Friday, September 09, 2022

BioStem Technologies, Inc. Second Quarter Financial Results Call, August 22, 2022
BioStem Technologies

Thursday, September 08, 2022

BioStem Technologies Reports 133% Year-Over-Year Revenue Growth As It Expands Distribution of Patented Allograft Tech
Rachael Green - Sponsored

Thursday, June 23, 2022

BioStem Technologies' Local MicroEnvironment Activation Possible Key To Reversing And Repairing Diseases-Caused Tissue Damage
Jacinta Sherris

Friday, June 17, 2022

Benzinga Announces This Week's All Access Guests
Kenneth Adams

Monday, May 16, 2022

EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
Michael Cohen

Thursday, April 22, 2021

Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness
Jelena Martinovic

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved